Roivant Sciences Ltd
ROIV
Get informed when a big investor buys or sells
+ FollowMarket Cap$25.23B
Close$
$1.85
94.7% downside
Current Fair Value
94.7% downsideOvervalued by 94.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $25.23 Billion |
|---|---|
| Enterprise Value | $24.17 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.43 |
| Beta | 1.13 |
| Outstanding Shares | 720,776,739 |
Return
| Return on Equity | -6.29% |
|---|---|
| Return on Assets | -5.02% |
| Return on Invested Capital | -22.85% |
Valuation & Multiples
| P/E Ratio | -91.92 |
|---|---|
| PEG | 612.43 |
| Price to Sales | - |
| Price to Book Ratio | 5.82 |
| Enterprise Value to Revenue | 3208.51 |
| Enterprise Value to EBIT | -21.06 |
| Enterprise Value to Net Income | -91 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
$2.07 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.41
Average shareholder expectationRevenue Estimate
$3.92 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.0562▲ 30.08% |
|---|---|
| Total Calls | 9,843,270▲ 638.15% |
| Total Puts | 10,396,000▲ 932.11% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 83.26%▲ 7.74% |
|---|---|
| Total Invested | $20.31B▲ 38.47% |
| Investors Holding | 516▲ 50.00% |
ESG Score
No data